Menu
Currency
GWAS Study

Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy.

Ghesquieres H, Slager SL, Jardin F et al.

26460308 PubMed ID
GWAS Study Type
1537 Participants
64 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

GH
Ghesquieres H
SS
Slager SL
JF
Jardin F
VA
Veron AS
AY
Asmann YW
MM
Maurer MJ
FT
Fest T
HT
Habermann TM
BM
Bene MC
NA
Novak AJ
MS
Mareschal S
HC
Haioun C
LT
Lamy T
AS
Ansell SM
TH
Tilly H
WT
Witzig TE
WG
Weiner GJ
FA
Feldman AL
DA
Dogan A
CJ
Cunningham JM
OC
Olswold CL
MT
Molina TJ
LB
Link BK
MN
Milpied N
CD
Cox DG
SG
Salles GA
CJ
Cerhan JR
Chapter II

Abstract

Summary of the research findings

Purpose: We performed a multistage genome-wide association study to identify inherited genetic variants that predict outcome in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

852 European ancestry cases

Chapter III

Study Statistics

Key metrics and study information

1537
Total Participants
GWAS
Study Type
Yes
Replicated
685 European ancestry cases
Replication Participants
European
Ancestry
U.S., France
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.